Email: [email protected]
A government scientific adviser, Sir Jeremy Farrar says there would be more than one coronavirus vaccine in the first quarter of 2021.
Speaking with Sky News, Sir Farrar said: “I think in the first quarter of next year we will have vaccines – will have more than one vaccine.”
The scientific adviser also said it will be “tough this year” and won’t be a normal Christmas for almost everybody”.
Sir Farrar is expecting vaccines data between November and December, assuring that the UK will have a “portfolio” of potential options.
The scientist is also hoping that the vaccine will make a lot of difference in early 2021.
His statement is similar to England’s Deputy Chief Medical Officer Jonathan Van-Tam who reportedly said a mass rollout of the jab, created at the University of Oxford and manufactured by AstraZeneca could be readily available next year.
The Sunday Times had reported that thousands of NHS workers will be trained to administer the vaccine, which is believed to be readily available immediately after Christmas.
Professor Van-Tam reportedly said during a briefing to MPs on Monday afternoon that jabs aren’t far away from being available.
“It isn’t a totally unrealistic suggestion that we could deploy a vaccine soon after Christmas,” adding that the vaccine would have a “significant impact on hospital admissions and deaths”.
Professor Van-Tam is said to be expecting the third stage result on the vaccine from Oxford/AstraZeneca probably by the end of November.
The Mail on Sunday reported that Pfizer has manufactured hundred of thousand doses of a jab in Belgium.
Pfizer is reportedly planning to make 100m doses in 2020 of which, 40m will be supplied to the UK, and the company is reportedly planning to increase the production to 1.3bn jabs next year.
On Sophy Ridge on Sunday, Sir Jeremy said the vaccine taskforce “has done an absolutely extraditory job”, assuring that the UK is in an extraordinarily strong position”.
“Britain has access to a number of different vaccines across a range of different approaches.
“Vaccines come in all different styles and approaches and Britain has got a portfolio of vaccines, through which more than one, I’m sure, will come through in the first quarter of next year,” he added.
Optimistically, he added: “I do believe that monoclonal antibodies to treat patients and save lives will be available in the coming months.”